Business Segment Information (Tables)
|
12 Months Ended |
Mar. 31, 2020 |
|---|
| Segment Reporting Information [Line Items] |
|
| Schedule of Segment Reporting Information, by Segment |
| | | | | | | | | | | | | | Years Ended March 31, | | 2020 | | 2019 | | 2018 | Revenues: | | | | | | | Healthcare Products | | $ | 1,423,198 |
| | $ | 1,338,428 |
| | $ | 1,276,054 |
| Healthcare Specialty Services | | 563,611 |
| | 510,057 |
| | 469,065 |
| Life Sciences | | 416,939 |
| | 378,558 |
| | 361,590 |
| Applied Sterilization Technologies | | 627,147 |
| | 555,127 |
| | 513,287 |
| Total revenues | | $ | 3,030,895 |
| | $ | 2,782,170 |
| | $ | 2,619,996 |
| Operating income (loss): | | | | | | | Healthcare Products | | 356,419 |
| | 323,684 |
| | 294,162 |
| Healthcare Specialty Services | | 64,217 |
| | 64,222 |
| | 58,458 |
| Life Sciences | | 144,088 |
| | 132,129 |
| | 123,889 |
| Applied Sterilization Technologies | | 270,917 |
| | 221,828 |
| | 196,297 |
| Total reportable segments | | 835,641 |
| | 741,863 |
| | 672,806 |
| Corporate | | (207,015 | ) | | (184,900 | ) | | (162,999 | ) | Total operating income before adjustments | | $ | 628,626 |
| | $ | 556,963 |
| | $ | 509,807 |
| Less: Adjustments | | | | | | | Amortization of acquired intangible assets (1) | | 71,675 |
| | 86,878 |
| | 67,793 |
| Acquisition and integration related charges (2) | | 8,225 |
| | 8,901 |
| | 16,211 |
| Redomiciliation and tax restructuring costs (3) | | 3,699 |
| | 8,783 |
| | — |
| (Gain) on fair value adjustment of acquisition related contingent consideration (1) | | — |
| | (842 | ) | | (593 | ) | Net loss (gain) on divestiture of businesses (1) | | 1,770 |
| | (1,370 | ) | | 14,547 |
| Amortization of property "step up" to fair value (1) | | 2,392 |
| | 2,440 |
| | 1,599 |
| Restructuring charges (4) | | 3,143 |
| | 40,708 |
| | 103 |
| Impact of the U.S. Tax Cuts and Jobs Act (5) | | — |
| | — |
| | 10,264 |
| COVID-19 incremental costs (6) | | 749 |
| | — |
| | — |
| Total operating income | | $ | 536,973 |
| | $ | 411,465 |
| | $ | 399,883 |
|
|
| Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area |
| | | | | | | | | | March 31, | | 2020 | | 2019 | Property, Plant, and Equipment, Net | | | | | Ireland | | $ | 47,459 |
| | $ | 41,137 |
| United States | | 632,333 |
| | 577,113 |
| Other locations | | 432,063 |
| | 413,332 |
| Property, Plant, and Equipment, Net | | $ | 1,111,855 |
| | $ | 1,031,582 |
|
|
| Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] |
| | | | | | | | | | | | | | Years Ended March 31, | | 2020 | | 2019 | | 2018 | Revenues: | | | | | | | Ireland | | $ | 63,821 |
| | $ | 56,784 |
| | $ | 48,246 |
| United States | | 2,211,722 |
| | 1,976,814 |
| | 1,836,414 |
| Other locations | | 755,352 |
| | 748,572 |
| | 735,336 |
| Total Revenues | | $ | 3,030,895 |
| | $ | 2,782,170 |
| | $ | 2,619,996 |
|
|
| Revenue from External Customers by Products and Services [Table Text Block] |
| | | | | | | | | | | | | | Years Ended March 31, | | 2020 | | 2019 | | 2018 | Healthcare Products: | | | | | | | Capital equipment | | $ | 592,436 |
| | 568,811 |
| | 527,402 |
| Consumables | | 454,518 |
| | 414,969 |
| | 412,495 |
| Service | | 376,244 |
| | 354,648 |
| | 336,157 |
| Total Healthcare Products Revenues | | $ | 1,423,198 |
| | $ | 1,338,428 |
| | $ | 1,276,054 |
| Total Healthcare Specialty Services Revenues | | $ | 563,611 |
| | $ | 510,057 |
| | $ | 469,065 |
| Life Sciences: | | | | | | | Capital equipment
| | $ | 112,747 |
| | 102,714 |
| | 100,555 |
| Consumables | | 185,904 |
| | 161,780 |
| | 150,656 |
| Service | | 118,288 |
| | 114,064 |
| | 110,379 |
| Total Life Sciences Revenues | | $ | 416,939 |
| | $ | 378,558 |
| | $ | 361,590 |
| Applied Sterilization Technologies Service Revenues | | $ | 627,147 |
| | $ | 555,127 |
| | $ | 513,287 |
| Total Revenues | | $ | 3,030,895 |
| | $ | 2,782,170 |
| | $ | 2,619,996 |
|
Effective April 1, 2020, and consistent with the way management will operate and view the business, the current Healthcare Products and Healthcare Specialty Services segments will be combined and reported as one segment, simply called Healthcare. Going forward we will operate and report in three business segments: Healthcare, Life Sciences and Applied Sterilization Technologies. Corporate will continue to be presented separately and contain the costs that are associated with being a publicly traded company and certain other corporate costs.
|
| Other Expense |
|
| Segment Reporting Information [Line Items] |
|
| Schedule of Segment Reporting Information, by Segment |
| | | | | | | | | | | | | | Years Ended March 31, | | 2020 | | 2019 | | 2018 | Capital Expenditures | | | | | | | Healthcare Products and Life Sciences | | $ | 44,029 |
| | $ | 49,688 |
| | $ | 52,767 |
| Healthcare Specialty Services | | 40,619 |
| | 39,950 |
| | 16,497 |
| Applied Sterilization Technologies | | 129,868 |
| | 100,077 |
| | 96,193 |
| Total Capital Expenditures | | $ | 214,516 |
| | $ | 189,715 |
| | $ | 165,457 |
| Depreciation, Depletion, and Amortization | | | | | | | Healthcare Products and Life Sciences (1) (2) | | $ | 59,150 |
| | $ | 81,264 |
| | $ | 52,025 |
| Healthcare Specialty Services | | 33,043 |
| | 33,392 |
| | 29,269 |
| Applied Sterilization Technologies (1) | | 105,042 |
| | 111,265 |
| | 97,038 |
| Total Depreciation, Depletion, and Amortization | | $ | 197,235 |
| | $ | 225,921 |
| | $ | 178,332 |
|
|
| Assets |
|
| Segment Reporting Information [Line Items] |
|
| Schedule of Segment Reporting Information, by Segment |
| | | | | | | | | | March 31, | | 2020 | | 2019 | Assets: | | | | | Healthcare Products and Life Sciences | | $ | 1,809,636 |
| | $ | 1,611,852 |
| Healthcare Specialty Services | | 895,741 |
| | 805,349 |
| Applied Sterilization Technologies | | 2,720,205 |
| | 2,655,870 |
| Total assets | | $ | 5,425,582 |
| | $ | 5,073,071 |
|
|